Exact Mass: 315.1318
Exact Mass Matches: 315.1318
Found 86 metabolites which its exact mass value is equals to given mass value 315.1318,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Neosaxitoxin
D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents > D009466 - Neuromuscular Blocking Agents Neosaxitoxin is produced by Protogonyaulax and found in shellfis D009676 - Noxae > D011042 - Poisons > D008978 - Mollusk Venoms D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins D009676 - Noxae > D011042 - Poisons > D014688 - Venoms D010575 - Pesticides > D007306 - Insecticides D016573 - Agrochemicals
N'-Hydroxysaxitoxin
N-Hydroxysaxitoxin is isolated from the crab Zosimus aeneus. Isolated from the crab Zosimus aeneus.
6-Amino-9-benzyl-2-(2-methoxyethoxy)-9H-purin-8-ol
Di-deacetyl adrogolide
Antramycin
ANTHRAMYCIN
A member of the class of pyrrolobenzodiazepines that is (11aS)-5,10,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine substituted at positions 2, 5, 8, 9 and 11R by a (1E)-3-amino-3-oxoprop-1-en-1-yl, oxo, methyl, hydroxy and hydroxy groups, respectively. It is a natural product isolated from Streptomyces refuineus subsp. thermotolerans. D000970 - Antineoplastic Agents
[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-4-yl-acetic acid
(R)-3-[((tert-Butoxy)carbonyl)amino]-4-(2,5-difluorophenyl)butanoic acid
[4-(4-fluoro-phenyl)-piperazin-1-yl]-pyridin-3-yl-acetic acid
BENZYL 2,4-DIOXO-3,4,5,6,8,9-HEXAHYDRO-1H-PYRIMIDO[4,5-D]AZEPINE-7(2H)-CARBOXYLATE
1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
N-(3-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide
N-(2-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide
5,6,7,8-TETRAHYDRO-6-(PHENYLMETHYL)-4H-THIENO[2,3-D]AZEPINE-2-CARBOXYLIC ACID, ETHYL ESTER
METHYL (2R)-2-[(TERT-BUTOXYCARBONYL)AMINO]-3-(2,5-DIFLUOROPHENYL)PROPANOATE
(3R)-3-[(tert-Butoxycarbonyl)amino]-4-(2,4-difluorophenyl)butanoic acid
3-((tert-butoxycarbonyl)amino)-4-(2,5-difluorophenyl)butanoic acid
BOC-(R)-3-AMINO-4-(3,4-DIFLUORO-PHENYL)-BUTYRIC ACID
N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)METHANESULFONAMIDE
TERT-BUTYL 3-(2,2-DIMETHYL-4,6-DIOXO-1,3-DIOXAN-5-YL)-3-OXOPROPYLCARBAMATE
Antramycin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents
N-(4-chlorophenyl)-2-[4-(2-methylpropyl)phenyl]propanamide
Doxepin hydrochloride
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D000890 - Anti-Infective Agents > D000935 - Antifungal Agents Doxepin hydrochloride is an orally active tricyclic antidepressant agent. Doxepin hydrochloride is a potent and selective histamine receptor H1 antagonist. Doxepin hydrochloride is also a potent CYP450 inhibitor and significantly inhibits CYP450 2C19 and 1A2[1][2]. Doxepin inhibits reuptake of serotonin and norepinephrine as a tricyclic antidepressant[3].. Doxepin has therapeutic effects in atopic dermatitis，chronic urticarial，can improve cognitive processes， protect central nervous system[4].. Doxepin has also been proposed as a protective factor against oxidative stress[5]..
Boc-(S)-3-amino-4-(3,4-difluoro-phenyl)-butyric acid
1-(9,10-DIHYDROANTHRACEN-9-YL)-3-(DIMETHYLAMINO)PROPAN-1-ONE HYDROCHLORIDE
Benzenamine,N-[(4-methoxyphenyl)methylene]-4-(2-phenyldiazenyl)-
3-METHOXY-4-[3-(1-PYRROLIDINYL)PROPOXY]-BENZOIC ACID HYDROCHLORIDE
(R)-5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-amine
1-(4-Methyl-1-piperidinyl)-2-[(3-methyl-2-quinoxalinyl)thio]ethanone
3H-Pyrazolo[3,4-b]pyridin-3-one, 2,7-dihydro-4,6-dimethyl-2,7-diphenyl-
6-(3-furanyl)-N-[(3-methylphenyl)methyl]-4-quinazolinamine
5-[(4-Methoxy-2-methylanilino)methylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione
N-(3-methoxypropyl)-2-(4-oxochromeno[4,3-c]pyrazol-1-yl)acetamide
(4Z)-5-methyl-4-[(1-methylindol-3-yl)methylidene]-2-phenylpyrazol-3-one
N-[(3,4,5-trimethoxyphenyl)methylideneamino]pyridine-3-carboxamide
(2S)-2-amino-N-[(E)-(6-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)methylidene]-3-phenylpropanehydrazide (non-preferred name)
N-[(E)-(2,5-Dimethoxyphenyl)methylideneamino]-1-methyl-6-oxopyridine-3-carboxamide
Neosaxitoxin
A pyrrolopurine that is saxitoxin carrying a hydroxy substituent on the nitrogen atom at position 5. It is a sodium channel blocker that is undergoing clinical trials as a prolonged-duration local anesthetic.
